GH Research PLC

GHRSNASDAQ · USD
24.45USD0.00 (-5.82%)
2310

GH Research PLC (GHRS) Option Chain

As of September 24, 2026, GH Research PLC is trading at $24.45, a -5.82% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 87.0%. IV Rank is 27%.

Read more

Tracking the GHRS option chain helps you see every strike and expiry on GH Research PLC in one view, so you can quickly identify the contracts that fit your thesis and your risk. GH Research PLC's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GHRS options activity at a glance. Use our scanner to monitor the GHRS option chain in real time and filter for the GHRS options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GHRS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GHRS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GHRS stock options are being actively traded and where they are not.

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders.

GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls GH Research PLC's full chain across every expiry, highlights the most liquid strikes, and lets you screen GHRS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GHRS stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile55.95% Neutral
  • Market cap (M$)1,678
  • 52 weeks high-22.23%
  • 52 weeks low103.07%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$41.70
    70.55% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.99
  • EPS growth next 5 years—

As of September 24, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.03102.106.957.1011.0017.50-32.59—4.900.004.900199.97
1.13002.054.454.508.5020.00-22.96—2.500.002.50014598.87
10.83502.651.952.706.5022.50-13.33—4.900.004.900089.17
38.202912.400.001.503.3025.00-3.70—1.500.550.950161.80
90.641311.950.00—1.9530.00+15.562.005.705.55-1.70069.36

As of September 24, 2026

Scan the full option chain in one place

Browse the full GHRS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial